212 related articles for article (PubMed ID: 24641548)
1. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
[TBL] [Abstract][Full Text] [Related]
2. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
3. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
[TBL] [Abstract][Full Text] [Related]
4. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
[TBL] [Abstract][Full Text] [Related]
5. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
[TBL] [Abstract][Full Text] [Related]
6. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
7. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
8. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.
Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA
Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160
[TBL] [Abstract][Full Text] [Related]
9. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
10. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
Haugaard-Kedström LM; Shabanpoor F; Hossain MA; Clark RJ; Ryan PJ; Craik DJ; Gundlach AL; Wade JD; Bathgate RA; Rosengren KJ
J Am Chem Soc; 2011 Apr; 133(13):4965-74. PubMed ID: 21384867
[TBL] [Abstract][Full Text] [Related]
12. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
13. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
14. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
[TBL] [Abstract][Full Text] [Related]
16. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5.
Wang JH; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2019 Apr; 51(4):619-626. PubMed ID: 30604098
[TBL] [Abstract][Full Text] [Related]
17. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation.
Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012
[TBL] [Abstract][Full Text] [Related]
18. A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.
Wang JH; Shao XX; Hu MJ; Wei D; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2017 May; 49(5):895-903. PubMed ID: 28161795
[TBL] [Abstract][Full Text] [Related]
19. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay.
Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565
[TBL] [Abstract][Full Text] [Related]
20. Involvement of relaxin-family peptide-3 receptor (RXFP3) in the ventral dentate gyrus of the hippocampus in spatial and fear memory in rats.
Vafaei Z; Khodagholi F; Nategh M; Nikseresht S; Hashemirad SR; Raise-Abdullahi P; Vafaei AA; Motamedi F
Peptides; 2024 Aug; 178():171244. PubMed ID: 38788901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
